The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,137,803 in first-year total cost, median $241,500.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]4
- HIV Comorbidities and Clinical Studies Study Section[HCCS]1
Most frequent institutions
- BOSTON MEDICAL CENTER1
- CASE WESTERN RESERVE UNIVERSITY1
- DUKE UNIVERSITY1
- MURDOCH CHILDREN'S RESEARCH INSTITUTE1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Defining the neovaginal microbiome after gender affirming vaginoplasty1R21AI178840-01A1 | FARR ZUEND, CHRISTINAPOPE, RACHEL JEAN | CASE WESTERN RESERVE UNIVERSITY, OH | $241,500 | HCCS |
| 2023 | Understanding the effects of cross-sex hormone therapy on vaginal mucosal immunity1R21AI178913-01 | INGALLS, ROBIN R | BOSTON MEDICAL CENTER, MA | $267,000 | HIVD |
| 2023 | A Mouse Model to Test the Effects of Gender-affirming Hormone Therapy on HIV Vaccine-induced Immune Responses1R21AI167768-01A1 | CAIN, DEREK WILSON | DUKE UNIVERSITY, NC | $255,190 | HIVD |
| 2023 | The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue1R21AI178872-01 | KAPPES, JOHN CHRISTOPHEROCHSENBAUER, CHRISTINA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $222,750 | HIVD |
| 2023 | Understanding the effects of Gender Affirming Hormone Therapy (GAHT) on immune function using a systems immunology approach1R21AI179004-01 | NOVAKOVIC, BORIS | MURDOCH CHILDREN'S RESEARCH INSTITUTE | $151,363 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.